Boards & Committees - Board of Directors
|BOARD OF DIRECTORS|
|COMMITTEE MEMBERS||COMMITTEE INFORMATION|
PAST BOARD MEETINGS:
ABOUT THE BOARD OF DIRECTORS
The ISHLT Board of Directors is comprised of 15 individuals: the four Officers (Past President, President, President-Elect, and Secretary-Treasurer) and eleven Directors, reflecting the geographic and disciplinary constituencies of the Society.
The Editor of the Journal of Heart and Lung Transplantion, the Medical Director of the Registry, the Annual Meeting Scientific Program Chair, the Chair of the Development Committee, and the Executive Director serve as ex-officio, non-voting members of the Board.
St. Vincent's Hospital
Professor Glanville trained in Sydney, Brompton Hospital, London and Stanford University, California. Currently working as a specialist in Lung Transplantation at St. Vincent's Hospital Sydney, he is actively involved with international trials into new immunosuppressive and anti-viral agents. He is Global Principal Investigator for the European and Australian Investigators in Lung Transplantation CeMyLungs trial, and sits on the Editorial Board of the American Journal of Respiratory and Critical Care Medicine. He has authored over 140 publications including approaches to antibody mediated rejection, bronchoscopic surveillance, RSV, CMV, Chlamydia and mycobacteria. He is the senior author of the International Guidelines for Lung Transplantation, foundation director of Outcomes Australia and a foundation member of ShareLife Australia.
University Heart Center Hamburg
Prof. Reichenspurner is currently the Medical Director, University Heart Center Hamburg, and Professor and Chairman of the Department of Cardiovascular Surgery. He was trained in Munich, Cape Town and Stanford University. He is actively involved in cardiac and pulmonary transplantation since 1985 and wrote his MD - and 2 PhD - theses about cardio-pulmonary transplantation and immunology.
He and his team have published over 460 articles, many of those focusing on transplantation. In addition, he is the spokesman of the Federal Medical Chamber in Germany for heart and lung transplantation and Head of the University Transplant Center in Hamburg.
Cleveland Clinic Foundation
Cleveland, Ohio, USA
Dr. Taylor is Professor of Medicine at the Cleveland Clinic Lerner College of Medicine of Case Western Reserve University in Cleveland, Ohio. Dr. Taylor is the Director of the Advanced Heart Failure and Transplant Cardiology Fellowship Program at Cleveland Clinic. Dr. Taylor completed his Internal Medicine residency, Cardiology fellowship, and Heart Failure/Transplant fellowship at the Medical College of Virginia in Richmond, Virginia. He remained on staff at MCV for one year prior to joining the U.T.A.H Cardiac Transplant Program in Salt Lake City in 1991. He moved to Cleveland Clinic in 2001.
St. Louis Children's Hospital
St. Louis, Missouri, USA
Stuart Sweet, MD, is Professor of Pediatrics at Washington University and Medical Director of the Pediatric Lung Transplant Program at St. Louis Children’s Hospital in St. Louis, Missouri. He received graduate and medical degrees at the University of Michigan and post-graduate training at Washington University. His current research focuses on lung disease in children and improved understanding of the important factors determining outcome after lung transplantation. He is currently leading an NIH funded multicenter collaborative study of the role viral infections play in pediatric lung transplant.
Dr. Sweet has active interests in organ allocation (he is currently Secretary of the OPTN/UNOS Board of Directors) and the use of information technology in medicine (he is chair of the Electronic Health Records committee at St. Louis Children's Hospital).
Cincinnati Children's Hospital Medical Center
Cincinnati, Ohio, USA
Lara Danziger-Isakov, MD, MPH, practices pediatric infectious diseases at Cincinnati Children's Hospital Medical Center where she is Associate Professor of Pediatrics at the University of Cincinnati. Dr. Danziger-Isakov earned her MD at Case Western Reserve University School of Medicine and complete her residency in Pediatrics at the Cleveland Clinic. She also completed a fellowship in Pediatric Infectious Diseases at Saint Louis Children's Hospital. Dr. Danziger-Isakov is board-certified in Pediatrics and Pediatric Infectious Diseases by the American Board of Pediatrics. Her clinical interests include pediatric infectious diseases, infections in transplant recipients, and infections in immunocompromised patients. Her research interests include outcomes related to infection after pediatric transplantation with an emphasis on pediatric and adult lung transplantation. In addition, Dr. Danziger-Isakov participates in clinical trials to evaluate both new infectious disease therapies and new method of detection for infectious diseases.
Newcastle Upon Tyne, UK
Andrew Fisher is Academic Director and Honorary Consultant Respiratory and Transplant Physician at the Institute of Transplantation, Freeman Hospital, Newcastle Upon Tyne and Professor of Respiratory Transplant Medicine at Newcastle University Medical School. He graduated from Nottingham University in 1993 and received research training as an Medical Research Council training fellow in Newcastle and Edinburgh 1996-99. He was subsequently awarded a GlaxoSmithKline Senior Clinical Research Fellowship 2005-2010. He has previously served as Chair of the British Thoracic Society Science and Research Committee 2009-2012 and Chair of the European Respiratory Society Lung Transplant Group 2010-2013.
Yale New Haven Hospital
New Haven, CT, USA
As a physician-scientist and transplant immunologist, Dr. Goldstein examines how the innate immune system, in particular Toll-like receptors, impact alloimmunity and transplant tolerance. His work as a board certified transplant cardiologist affords him insights into whether preclinical immunological studies are relevant to solid organ transplantation. In addition, his research involves studies on how aging impacts innate immunity and the role of aging on alloimmmunity. In particular, his laboratory has discovered new pathways by which aging alters inflammation during acute viral infections, atherosclerosis, and information that age-induced inflammatory responses impact the tempo of acute allograft rejection and transplant tolerance.
University of Wisconsin
Madison, WI, USA
Maryl R. Johnson, MD, received her medical degree from the University of Iowa College of Medicine where she also completed postgraduate training in Internal Medicine and Cardiovascular Diseases. She joined the faculty at Iowa and was instrumental in the establishment of a cardiac transplant program, serving as the Medical Director of Cardiac Transplantation from 1984-1988. Her subsequent career has been entirely devoted to the care of patients with heart failure and following cardiac transplantation. She served as the Associate Medical Director of the Cardiac Transplant Program at Loyola University Medical Center from 1988-1994, Associate Medical Director of the Rush Heart Failure and Cardiac Transplant Program from 1994-1997, and Medical Director, Heart Failure and Transplantation at Northwestern Memorial Hospital from 1998-2002. She moved to the University of Wisconsin as Medical Director of Heart Failure and Transplantation and Professor of Medicine in July 2002.
Dr. Johnson's clinical interests are in the care of patients with severe congestive heart failure, including the use of mechanical circulatory support devices and cardiac transplantation. She has a particular interest in the treatment and outcome of congestive heart failure in women. Her research interests include the use of mechanical assistance in patients with severe heart failure and the coronary artery disease which develops in cardiac transplant recipients. She has also been an investigator in many of the multicenter trials evaluating new agents for the medical treatment of heart failure.
Newcastle, UNITED KINGDOM
Dr. Richard Kirk trained at Christ's College, Cambridge University and Guy's Hospital graduating in 1979. His general paediatric training was principally undertaken in Bristol Royal Hospital for Sick Children and Alder Hey Children's Hospital (the largest children's hospital in Europe). His specialist training in Paediatric Cardiology was undertaken at Harefield Hospital and Freeman Hospital in the UK, Boston Children's Hospital and the University of California, San Francisco in the USA and the Royal Children's Hospital, Melbourne in Australia. Following his training, he was appointed consultant to the University Hospital of Wales and established the Paediatric and Fetal Cardiac Service for South Wales which achieved UK recognition as a centre of excellence. In 2001 he moved to Singapore and was Head of the Department of Paediatric Cardiology at the National University Hospital. In 2004 he returned to the UK and currently works in the Department of Paediatric Cardiothoracic Services at the Freeman Hospital.
A/Prof Bronwyn Levvey is the clinical lung transplant nursing team leader of the Lung Transplant Service at The Alfred Hospital, Melbourne Australia. Appointed as Adjunct Clinical Associate Professor in the Department of Medicine, Faculty of Nursing & Health Sciences at Monash University (Melbourne) in 2008 in recognition of her strong commitment to transplantation nursing education and clinical research, she has authored or co-authored more than 60 peer review scientific publications. Since 2005, a major focus of A/Prof Levvey’s clinical research has been the successful evolution and development of Category III DCD Lung donation and transplantation in Australia. An ISHLT member since 2000, she is the current National President of the Transplant Nurses Association (TNA) of Australia, a member of TTS and the Transplantation Society of Australia & New Zealand (TSANZ), and is a member of several Australian government organ donation and transplantation advisory boards.
University of Michigan Health System
Ann Arbor, Michigan, USA
Francis D. Pagani, M.D., Ph.D. is the Otto Gago, MD Professor of Surgery at the University of Michigan. He is the Surgical Director of the Heart Transplant Program and the Center for Circulatory Support at the University of Michigan Health System. Dr. Pagani earned his doctorate in pharmacology and medical degree from Georgetown University in 1986 and completed his Chief Residency in Surgery at Georgetown University in 1993. Dr. Pagani completed a post doctural fellowship in cardiac research at the University of Massachusetts from 1988 to 1990. Dr. Pagani joined the University of Michigan faculty in 1995. His research focuses on the use of mechanical circulatory support in the treatment of end-stage heart disease and also has investigated the use of cellular transplantation for myocardial regeneration. His clinical interests include adult cardiac surgery for advanced heart disease, valvular heart disease, heart transplantation, and mechanical circulatory support.
University of Maryland School of Medicine
Baltimore, MD, USA
Bio coming soon...
Duke University Medical Center
Durham, North Carolina, USA
Bio coming soon...
University Heart Center Leipzig
49-341865 1319 / 1421
Bio coming soon...
Univ of California San Francisco
San Francisco, California, USA
Bio coming soon...
University of Alberta
Edmonton, Alberta, CANADA
Dr. Lori West is the Director of Heart Transplantation Research and a Professor of Pediatrics, Surgery and Immunology at the University of Alberta - one of the largest heart transplant programs in the world. Dr. West completed her pediatric residency at Harbor-UCLA Medical Center. She trained in pediatric cardiology at the Hospital for Sick Children, Toronto, and subsequently in pediatric transplant cardiology at Pittsburgh Children's Hospital, Loma Linda University Medical Center and Columbia-Presbyterian Children's Hospital. She obtained her PhD for specialized training in transplant immunology research at Oxford University and works in the role of a clinician-scientist.
University of Utah
Salt Lake City, Utah, USA
Josef Stehlik, MD, MPH is an Associate Professor of Medicine at the University of Utah School of Medicine. Dr. Stehlik received his medical degree from Charles University in Prague and Masters in Public Health degree from Harvard School of Public Health. He completed his training in Internal Medicine and in Cardiovascular Diseases at Allegheny General Hospital, MCP*Hahnemann University and advanced training in Heart Failure and Transplantation at the Cleveland Clinic. Dr. Stehlik has been on faculty at the University of Utah since 2004 and serves as Medical Director of the Heart Transplant Program at the University of Utah Hospital and the Salt Lake City Veterans Affairs Medical Center. He has been active in clinical work, education and research in the areas of advanced heart failure, heart transplantation and mechanical circulatory support.
Professor of Medicine, Harvard Medical School
Executive Director, Center for Advanced Heart Disease, Brigham and Women's Hospital
Boston, Massachusetts, USA
Dr. Mehra, an internationally recognized cardiologist with expertise in the treatment of heart failure and heart muscle damage, cardiac transplantation and mechanical circulatory devices, is professor of Medicine at Harvard Medical School and Executive Director of the Center for Advanced Heart Disease at the Brigham and Women's Hospital in Boston, MA (USA). He obtained his cardiovascular training at the Ochsner Clinic Foundation, where he sub-specialized in the field of advanced heart failure and cardiac transplantation. He is board certified in internal medicine and cardiovascular diseases. His specific research interests in cardiac transplantation focus on post-transplant coronary arterial disease, new immunosuppressive therapy to improve heart transplant outcomes, and bringing genomic and proteomic science (the study of protein interactions in the body) to the bedside. In the field of heart failure, his research has focused on the role of new devices and novel serum markers to guide diagnosis and therapy.
University of Pennsylvania
Philadelphia, Pennsylvania, USA
Jason Christie, MD, MS, is the Section Chief of Medical Critical Care at the University of Pennsylvania Perelman School of Medicine. He is currently Associate Professor of Epidemiology in the Department of Biostatistics and Epidemiology at the University of Pennsylvania. He is a Senior Scholar in the Center for Clinical Epidemiology and Biostatistics, and the Director of Clinical Research in the Pulmonary Division. His career is focused on translational research studies of the risks, pathogenesis, treatment, and outcomes of acute lung injury (ALI) in the transplant and non-transplant human populations.
The University of Chicago Medicine & Biological Sciences
Chicago, Illinois, USA
Christopher Wigfield, MD, MD, FRCS(C/Th), is Assistant Professor of Cardiothoracic Surgery at The University of Chicago. Dr. Wigfield received his clinical MD at Freie Universitaet Berlin, Germany and an additional Medical Sciences MD from the University of Newcastle upon Tyne, United Kingdom. He completed residencies in General Surgery at Royal Berkshire Hospital and at Freeman Hospital in the UK and went on to complete a fellowship in Cardiothoracic Surgery and Cardiopulmonary Transplantation at the Cardiothoracic Centre in Newcastle upon Tyne, UK. He also completed a Cardiothoracic Surgery fellowship at the University of Wisconsin Hospitals and Clinics in Madison, Wisconsin, USA. Dr. Wigfield's clinical and research interests are in thoracic surgery, lung transplantation, robotic assisted surgery and minimally invasive thoracic surgery. He has a dedicated educational portfolio.
14673 Midway Rd., Suite 200
Addison, Texas, 75001
Bio coming soon...